Tim Jasper Knotnerus
CIK: 0002120886
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AGMB
AgomAb Therapeutics NV
DirectorOfficer
Discretionary Trading P&L
Holdings
About Knotnerus Tim Jasper
Knotnerus Tim Jasper (SEC CIK 0002120886) files insider reports with the SEC as Chief Executive Officer of AgomAb Therapeutics NV (AGMB).
Signal8 holds 2 ownership filings by Knotnerus Tim Jasper (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Oct 7, 2026. Those filings report 2 transactions, from Oct 5, 2026 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Knotnerus Tim Jasper's filings is in ANTWERPEN.
Recent filings by Knotnerus Tim Jasper
Other insiders filing for AgomAb Therapeutics NV (AGMB)
- Epstein David R, Director
- Kemula Pierre Thadee Victor, Chief Financial Officer
- Garcia Marino, Director
- Patel Naimish, Director
- Bond Colin Michael, Director
- Hammer Ohad, Director